Inhibition of multidrug efflux as a strategy to prevent biofilm formation

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 3, 2014, Pages 673-681

  Baugh, Stephanie ^a   Phillips, Charlotte R ^a   Ekanayaka, Aruna S ^a   Piddock, Laura J V ^a   Webber, Mark A ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Acrab tolc; Curli; Efflux inhibitors

Indexed keywords

CARRIER PROTEIN;

BIOFILM; DRUG EFFECTS; ESCHERICHIA COLI; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PHYSIOLOGY; PSEUDOMONAS AERUGINOSA; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; STAPHYLOCOCCUS AUREUS;

BIOFILMS; ESCHERICHIA COLI; MEMBRANE TRANSPORT PROTEINS; PSEUDOMONAS AERUGINOSA; SALMONELLA TYPHIMURIUM; STAPHYLOCOCCUS AUREUS;

EID: 84894052600     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt420     Document Type: Article

References (16)

1. Costerton JW, Cheng KJ, Geesey GG et al. Bacterial biofilms in nature and disease. Ann Rev Microbiol 1987; 41: 435-64.
2. Lewis K. Persister cells, dormancy and infectious disease. Nat Rev Microbiol 2007; 5: 48-56.
3. Watnick P, Kolter R. Biofilm, city of microbes. J Bacteriol 2000; 182: 2675-9.
4. Baugh S, Ekanayaka AS, Piddock LJV et al. Loss of any of the multidrug efflux pumps of Salmonella Typhimurium results in a loss of ability to form a biofilm. J Antimicrob Chemother 2012; 67: 2409-17.
5. Kvist M, Hancock V, Klemm P. Inactivation of efflux pumps abolishes bacterial biofilm formation. Appl Environ Microbiol 2008; 74: 7376-82.
6. De Kievit TR, Parkins MD, Gillis RJ et al. Multidrug efflux pumps: expression patterns and contribution to antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 2001; 45: 1761-70.
7. Ramage G, Bachmann S, Patterson TF et al. Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. J Antimicrob Chemother 2002; 49: 973-80.
8. Gerstel U, Park C,Romling U.Complex regulation of csgD promoteractivity by global regulatory proteins. Mol Microbiol 2003; 49: 639-54.
9. Nishino K, Latifi T, Groisman EA. Virulence and drug resistance roles of multidrug efflux systems of Salmonella enterica serovar Typhimurium. Mol Microbiol 2006; 59: 126-41.
10. Ebel-Tsipis J, Fox MS, Botstein D.Generalized transductionbybacteriophage P22 in Salmonella typhimurium. II. Mechanism of integration of transducing DNA. J Mol Biol 1972; 71: 449-69.
11. Benoit MR, Conant CG, Ionescu-Zanetti C et al. New device for high-throughput viability screening of flow biofilms. Appl Environ Microbiol 2010; 76: 4136-42.
12. Blair JM, La Ragione RM,WoodwardMJet al. Periplasmic adaptor protein AcrA has a distinct role in the antibiotic resistance and virulence of Salmonella enterica serovar Typhimurium. J Antimicrob Chemother 2009; 64: 965-72.
13. Bailey AM, Paulsen IT, Piddock LJ. RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine. Antimicrob Agents Chemother 2008; 52: 3604-11.
14. Monteiro C, Fang X, Ahmad I et al. Regulation of biofilm components in Salmonella enterica serovar Typhimurium by lytic transglycosylases involved in cell wall turnover. J Bacteriol 2011; 193: 6443-51.
15. Dueholm MS, Albertsen M, Otzen D et al. Curli functional amyloid systems are phylogenetically widespread and display large diversity in operon and protein structure. PLoS One 2012; 7: e51274.
16. LomovskayaO,WarrenMS, LeeAetal. Identificationandcharacterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob Agents Chemother 2001; 45: 105-16.